TickerGuard
Buy Day today: Neutral (47) Mixed market breadth · no major macro event
CTEV

Claritev Corporation

Healthcare · Health Information Services

25.00$ +3.9% vs. previous close Closing price · As of: Oct 7, 2026

Statements

Cash Flow

Claritev Corporation (CTEV) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at 93 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow CTEV
Line item Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
147 44 140 380 171 33 167 33 195 41 109 28 64 7.7 72 28 50 18 73 -34 -30 61 20 66 -46 93 133
100 101 101 – 103 104 103 103 103 104 104 104 105 106 107 108 108 109 110 110 112 112 113 112 112 111 447
9.4 28 262 – 1.0 7.5 4.8 4.8 3.1 4.1 4.1 5.4 3.7 4.8 4.8 4.7 5.7 7.3 6.8 6.8 6.7 6.7 7.0 7.8 6.9 7.4 29
-6.8 7.3 81 21 105 -163 104 -91 90 -67 108 -76 -15 -19 34 -21 16 -37 29 -22 -40 33 -71 49 -80 44 -58
17 18 14 71 18 19 20 27 24 19 21 26 23 32 22 31 31 25 32 30 39 25 36 30 47 38 151
-17 -18 -115 889 -162 -18 -20 -27 -24 -34 -21 -26 -23 -173 -22 -31 -31 -25 -32 -30 -39 -25 -23 -35 -47 -38 -142
– – – – -0.3 -2.1 -59 -39 – – – -100 -5.7 -7.4 – -2.1 -10 0.0 0.0 0.0 0.3 0.0 0.0 0.0 – -3.5 –
– – – – – – – – – – – – – – – – – – -3.3 -3.2 80 -3.7 -14 -54 101 -59 -25
98 -98 0.0 -1,167 -0.2 -2.1 -70 -43 -5.3 -3.6 -3.5 -103 -109 -11 -38 -22 -31 -3.0 -3.1 -3.0 73 -3.2 -14 -54 99 -62 -30
228 -0.4 0.2 124 8.3 13 77 -37 165 3.3 85 -101 -68 -176 12 -26 -12 -10 38 -67 4.2 33 -17 -22 6.4 -7.1 -40
130 27 126 309 153 15 147 5.9 170 22 88 2.2 41 -24 50 -3.6 19 -7.0 41 -64 -69 37 -16 36 -93 55 -18

LTM = last twelve months (sum of the four most recent quarters).

Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?